Novo pulls plug on drug seen as key to its growth
Submitted by ipsita on Sun, 1997-12-28 10:30
In a major blow to growth prospects, Novo Nordisk As scuttled development of levermeloxifene, a ballyhooed drug in advanced testing against osteporosis. Levormeloxifene had been viewed as the crown
Main Topic:
Mark Content Private(Internal):
Clipping Type:
DNB
External URL:
Main Type:
dte-DNB
Publication Date:
28/12/1997